Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Ny spesialistutdanning og konsekvenser for radiologi.

Halvorsen EH, Eng TF, Brøgger HMB, Søvik E.

Tidsskr Nor Laegeforen. 2019 Oct 7;139(14). doi: 10.4045/tidsskr.19.0436. Print 2019 Oct 8. Norwegian. No abstract available.

PMID:
31592610
Free Article
2.

Complete Genome Sequence of Agrobacterium sp. Strain 33MFTa1.1, Isolated from Thlaspi arvense Roots.

Langley S, Eng T, Wan KH, Herbert RA, Klein AP, Yoshikuni Y, Tringe SG, Brown JB, Celniker SE, Mortimer JC, Mukhopadhyay A.

Microbiol Resour Announc. 2019 Sep 12;8(37). pii: e00432-19. doi: 10.1128/MRA.00432-19.

3.

Clinical Outcomes of Spatially Fractionated GRID Radiotherapy in the Treatment of Bulky Tumors of the Head and Neck.

Choi JI, Daniels J, Cohen D, Li Y, Ha CS, Eng TY.

Cureus. 2019 May 10;11(5):e4637. doi: 10.7759/cureus.4637.

4.

Rhizobacteria Mediate the Phytotoxicity of a Range of Biorefinery-Relevant Compounds.

Herbert RA, Eng T, Martinez U, Wang B, Langley S, Wan K, Pidatala V, Hoffman E, Chen JC, Bissell MJ, Brown JB, Mukhopadhyay A, Mortimer JC.

Environ Toxicol Chem. 2019 Sep;38(9):1911-1922. doi: 10.1002/etc.4501. Epub 2019 Jul 26. Review.

5.

Zebrafish facial lymphatics develop through sequential addition of venous and non-venous progenitors.

Eng TC, Chen W, Okuda KS, Misa JP, Padberg Y, Crosier KE, Crosier PS, Hall CJ, Schulte-Merker S, Hogan BM, Astin JW.

EMBO Rep. 2019 May;20(5). pii: e47079. doi: 10.15252/embr.201847079. Epub 2019 Mar 15.

PMID:
30877134
6.

Engineering Corynebacterium glutamicum to produce the biogasoline isopentenol from plant biomass hydrolysates.

Sasaki Y, Eng T, Herbert RA, Trinh J, Chen Y, Rodriguez A, Gladden J, Simmons BA, Petzold CJ, Mukhopadhyay A.

Biotechnol Biofuels. 2019 Feb 27;12:41. doi: 10.1186/s13068-019-1381-3. eCollection 2019.

7.

Engineering Robust Production Microbes for Large-Scale Cultivation.

Wehrs M, Tanjore D, Eng T, Lievense J, Pray TR, Mukhopadhyay A.

Trends Microbiol. 2019 Jun;27(6):524-537. doi: 10.1016/j.tim.2019.01.006. Epub 2019 Feb 25. Review.

8.

A quantitative measure for radiation treatment plan quality.

Laura Licon A, Defoor D, Ford J, Crownover R, Li Y, Ha C, Eng T, Jones W, Mavroidis P, Papanikolaou N, Stathakis S.

J BUON. 2018 Sep-Oct;23(5):1460-1466.

9.

Restoration of biofuel production levels and increased tolerance under ionic liquid stress is enabled by a mutation in the essential Escherichia coli gene cydC.

Eng T, Demling P, Herbert RA, Chen Y, Benites V, Martin J, Lipzen A, Baidoo EEK, Blank LM, Petzold CJ, Mukhopadhyay A.

Microb Cell Fact. 2018 Oct 8;17(1):159. doi: 10.1186/s12934-018-1006-8.

10.

Characterization of Zebrafish Facial Lymphatics.

Eng TCY, Astin JW.

Methods Mol Biol. 2018;1846:71-83. doi: 10.1007/978-1-4939-8712-2_5.

PMID:
30242753
11.

Dosimetric Evaluation of Pinnacle's Automated Treatment Planning Software to Manually Planned Treatments.

McConnell KA, Marston T, Zehren BE, Lirani A, Stanley DN, Bishop A, Crownover R, Eng T, Shi Z, Li Y, Baacke D, Kirby N, Rasmussen K, Papanikolaou N, Gutierrez AN.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818780064. doi: 10.1177/1533033818780064.

12.

Modeling the target dose fall-off in IMRT and VMAT planning techniques for cervical SBRT.

Brito Delgado A, Cohen D, Eng TY, Stanley DN, Shi Z, Charlton M, Gutiérrez AN.

Med Dosim. 2018 Spring;43(1):1-10. doi: 10.1016/j.meddos.2017.07.009. Epub 2017 Dec 6.

PMID:
29223302
13.

Improving membrane protein expression and function using genomic edits.

Jensen HM, Eng T, Chubukov V, Herbert RA, Mukhopadhyay A.

Sci Rep. 2017 Oct 12;7(1):13030. doi: 10.1038/s41598-017-12901-7.

14.

Assessing dose variance from immobilization devices in VMAT head and neck treatment planning: A retrospective case study analysis.

Olson A, Phillips K, Eng T, Lenards N, Hunzeker A, Lewis D, Baumann D.

Med Dosim. 2018 Spring;43(1):39-45. doi: 10.1016/j.meddos.2017.08.001. Epub 2017 Sep 15.

PMID:
28927550
15.

Prescribed and Measured Dose Differences for an AP-PA TBI Protocol with Compensation Filter and Ergonomic Patient Support.

Mesa Linares F, Papanikolaou N, Esquivel C, Eng TY, Fuller CD, Sosa M.

J Med Imaging Radiat Sci. 2017 Sep;48(3):301-306. doi: 10.1016/j.jmir.2017.06.001. Epub 2017 Jul 10.

PMID:
31047414
16.

Treatment and Outcomes of Primary Urethra Cancer.

Eng TY, Chen TW, Patel AJ, Vincent JN, Ha CS.

Am J Clin Oncol. 2018 Sep;41(9):905-908. doi: 10.1097/COC.0000000000000391.

PMID:
28537991
17.

Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer.

Eng TY, Patel AJ, Ha CS.

Brachytherapy. 2016 May-Jun;15(3):312-318. doi: 10.1016/j.brachy.2016.02.008. Epub 2016 Mar 28.

PMID:
27032995
18.

Persistent Disparities in Hispanics with Cervical Cancer in a Major City.

Eng TY, Chen T, Vincent J, Patel AJ, Clyburn V, Ha CS.

J Racial Ethn Health Disparities. 2017 Apr;4(2):165-168. doi: 10.1007/s40615-016-0214-3. Epub 2016 Mar 11.

PMID:
26969160
19.
20.

Radiation Therapy in Gastric and Ocular Marginal Zone Lymphomas.

Luh JY, Harmon MW, Eng TY, Thomas CR.

Mayo Clin Proc. 2016 Jan;91(1):123. doi: 10.1016/j.mayocp.2015.10.012. No abstract available.

PMID:
26763518
21.

Image-guided radiation therapy in lymphoma management.

Eng T, Ha CS.

Radiat Oncol J. 2015 Sep;33(3):161-71. doi: 10.3857/roj.2015.33.3.161. Epub 2015 Sep 30. Review.

22.

p53-based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study.

Ha CS, Michalek JE, Elledge R, Kelly KR, Ganapathy S, Su H, Jenkins CA, Argiris A, Swords R, Eng TY, Karnad A, Crownover RL, Swanson GP, Goros M, Pollock BH, Yuan ZM.

Mol Oncol. 2016 Jan;10(1):148-56. doi: 10.1016/j.molonc.2015.09.004. Epub 2015 Sep 18.

23.

Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.

Stanley DN, Popp T, Ha CS, Swanson GP, Eng TY, Papanikolaou N, Gutiérrez AN.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e625-33. doi: 10.1016/j.prro.2015.06.012. Epub 2015 Jul 7.

PMID:
26419443
24.

Interallelic complementation provides functional evidence for cohesin-cohesin interactions on DNA.

Eng T, Guacci V, Koshland D.

Mol Biol Cell. 2015 Nov 15;26(23):4224-35. doi: 10.1091/mbc.E15-06-0331. Epub 2015 Sep 16.

25.

A conserved domain in the scc3 subunit of cohesin mediates the interaction with both mcd1 and the cohesin loader complex.

Orgil O, Matityahu A, Eng T, Guacci V, Koshland D, Onn I.

PLoS Genet. 2015 Mar 6;11(3):e1005036. doi: 10.1371/journal.pgen.1005036. eCollection 2015 Mar.

26.

Monitoring and reporting hospital-acquired conditions: a federalist approach.

West N, Eng T.

Medicare Medicaid Res Rev. 2015 Jan 6;4(4). pii: mmrr2014-004-04-a04. doi: 10.5600/mmrr.004.04.a04. eCollection 2014.

27.

An in vivo antilymphatic screen in zebrafish identifies novel inhibitors of mammalian lymphangiogenesis and lymphatic-mediated metastasis.

Astin JW, Jamieson SM, Eng TC, Flores MV, Misa JP, Chien A, Crosier KE, Crosier PS.

Mol Cancer Ther. 2014 Oct;13(10):2450-62. doi: 10.1158/1535-7163.MCT-14-0469-T. Epub 2014 Jul 22.

29.

ROCC, a conserved region in cohesin's Mcd1 subunit, is essential for the proper regulation of the maintenance of cohesion and establishment of condensation.

Eng T, Guacci V, Koshland D.

Mol Biol Cell. 2014 Aug 15;25(16):2351-64. doi: 10.1091/mbc.E14-04-0929. Epub 2014 Jun 25.

30.

Bereavement in the elderly: the role of primary care.

Hashim SM, Eng TC, Tohit N, Wahab S.

Ment Health Fam Med. 2013 Sep;10(3):159-62.

31.

Measurement of neutron dose equivalent outside and inside of the treatment vault of GRID therapy.

Wang X, Charlton MA, Esquivel C, Eng TY, Li Y, Papanikolaou N.

Med Phys. 2013 Sep;40(9):093901. doi: 10.1118/1.4816653.

PMID:
24007186
32.

Stimulant medication and substance use outcomes: a meta-analysis.

Humphreys KL, Eng T, Lee SS.

JAMA Psychiatry. 2013 Jul;70(7):740-9. doi: 10.1001/jamapsychiatry.2013.1273.

33.

Posttreatment prostate-specific antigen surveillance after primary treatment of prostate cancer.

Luh JY, Harmon MW, Eng TY.

Mayo Clin Proc. 2013 Mar;88(3):307-8. doi: 10.1016/j.mayocp.2012.12.003. Epub 2013 Feb 27. No abstract available.

PMID:
23489460
34.

Monte Carlo modeling of a Novalis Tx Varian 6 MV with HD-120 multileaf collimator.

Vazquez-Quino LA, Massingill B, Shi C, Gutierrez A, Esquivel C, Eng T, Papanikolaou N, Stathakis S.

J Appl Clin Med Phys. 2012 Sep 6;13(5):3960. doi: 10.1120/jacmp.v13i5.3960.

35.

Preferences of Malaysian cancer patients in communication of bad news.

Eng TC, Yaakup H, Shah SA, Jaffar A, Omar K.

Asian Pac J Cancer Prev. 2012;13(6):2749-52.

36.

Developmental control of gene copy number by repression of replication initiation and fork progression.

Sher N, Bell GW, Li S, Nordman J, Eng T, Eaton ML, Macalpine DM, Orr-Weaver TL.

Genome Res. 2012 Jan;22(1):64-75. doi: 10.1101/gr.126003.111. Epub 2011 Nov 16.

37.

Case report: automated machine checkout leaves an internal gas leak undetected: the need for complete checkout procedures.

Eng TS, Durieux ME.

Anesth Analg. 2012 Jan;114(1):144-6. doi: 10.1213/ANE.0b013e3182312c70. Epub 2011 Sep 29.

PMID:
21965366
38.

Integrative analysis of gene amplification in Drosophila follicle cells: parameters of origin activation and repression.

Kim JC, Nordman J, Xie F, Kashevsky H, Eng T, Li S, MacAlpine DM, Orr-Weaver TL.

Genes Dev. 2011 Jul 1;25(13):1384-98. doi: 10.1101/gad.2043111.

39.

Ubiquitin-dependent control of class II MHC localization is dispensable for antigen presentation and antibody production.

McGehee AM, Strijbis K, Guillen E, Eng T, Kirak O, Ploegh HL.

PLoS One. 2011 Apr 20;6(4):e18817. doi: 10.1371/journal.pone.0018817.

40.

Merkel cell carcinoma.

Ramahi E, Choi J, Fuller CD, Eng TY.

Am J Clin Oncol. 2013 Jun;36(3):299-309. doi: 10.1097/COC.0b013e318210f83c. Review.

41.

Developmental control of the DNA replication and transcription programs.

Nordman J, Li S, Eng T, Macalpine D, Orr-Weaver TL.

Genome Res. 2011 Feb;21(2):175-81. doi: 10.1101/gr.114611.110. Epub 2010 Dec 22.

42.

Radiotherapy for thymic neoplasms.

Fuller CD, Ramahi EH, Aherne N, Eng TY, Thomas CR Jr.

J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S327-35. doi: 10.1097/JTO.0b013e3181f20ec4. Review.

43.

Three dimensional intensity modulated brachytherapy (IMBT): dosimetry algorithm and inverse treatment planning.

Shi C, Guo B, Cheng CY, Esquivel C, Eng T, Papanikolaou N.

Med Phys. 2010 Jul;37(7):3725-37.

PMID:
20831080
44.

Applications of tissue heterogeneity corrections and biologically effective dose volume histograms in assessing the doses for accelerated partial breast irradiation using an electronic brachytherapy source.

Shi C, Guo B, Cheng CY, Eng T, Papanikolaou N.

Phys Med Biol. 2010 Sep 21;55(18):5283-97. doi: 10.1088/0031-9155/55/18/003. Epub 2010 Aug 18.

PMID:
20720283
45.

Radiation therapy for gynecomastia.

Luh JY, Harmon MW, Eng TY.

Mayo Clin Proc. 2010 Apr;85(4):398-9; author reply 399. doi: 10.4065/mcp.2009.0745. No abstract available.

46.

The effect of a limited number of projections and reconstruction algorithms on the image quality of megavoltage digital tomosynthesis.

Sarkar V, Shi C, Rassiah-Szegedi P, Diaz A, Eng T, Papanikolaou N.

J Appl Clin Med Phys. 2009 May 28;10(3):2970.

47.

Rating recommendations for consumers about patient safety: sense, common sense, or nonsense?

Weingart SN, Morway L, Brouillard D, Cleary A, Eng TK, Saadeh MG, Seger AC, Bates DW, Leape LL.

Jt Comm J Qual Patient Saf. 2009 Apr;35(4):206-15.

PMID:
19435160
48.

Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease.

Chua KH, Hilmi I, Ng CC, Eng TL, Palaniappan S, Lee WS, Goh KL.

J Dig Dis. 2009 May;10(2):124-30. doi: 10.1111/j.1751-2980.2009.00374.x.

PMID:
19426395
49.

A feasibility study on the use of digital tomosynthesis with individually-acquired megavoltage portal images for target localization.

Sarkar V, Shi C, Rassiah-Szegedi P, Eng T, Diaz A, Papanikolaou N.

J BUON. 2009 Jan-Mar;14(1):103-8.

50.

Evaluation of inter-fractional setup shifts for site-specific helical tomotherapy treatments.

Lin L, Shi C, Eng T, Swanson G, Fuss M, Papanikolaou N.

Technol Cancer Res Treat. 2009 Apr;8(2):115-22.

PMID:
19334792

Supplemental Content

Support Center